norcantharidin has been researched along with Medulloblastoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carotenuto, M; Cimmino, F; Dato, VD; De Antonellis, P; De Vita, G; Scoppettuolo, MN; Zollo, M | 1 |
1 other study(ies) available for norcantharidin and Medulloblastoma
Article | Year |
---|---|
Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling.
Topics: Animals; Antineoplastic Agents; Apoptosis; beta Catenin; Blood-Brain Barrier; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Flow Cytometry; Fluorescent Antibody Technique; G2 Phase; Genes, Reporter; Indicators and Reagents; Luciferases; Medulloblastoma; Mice; Mice, SCID; Neoplasm Transplantation; Polymerase Chain Reaction; Protein Transport; Signal Transduction; Wnt Proteins | 2012 |